Progen Industries . Announced today positive preliminary results from a Phase II study of PI-88 for the treatment of patients with primary liver cancer following surgical resection of the tumor. The study showed that PI-88 increased time, results, arecurrence by 76 percent.
The treatment of patients in a post – resection liver cancer setting is a very good match for the biological mechanism of action of PI-88 We know despite the patient’s surgery to remove the tumor are still small tumors. Available. PI-88 works through a process called angiogenesis, or the inhibition of the growth of new blood vessels to these tumors, and also to the spread of tumors or metastases. It is this dual mechanism of action that we believe PI-88 has the potential an exciting an exciting alternative to current cancer therapies.
In the next 40 years, nearly all of the 2.3 billion projected increase will be in the less developed regions, with nearly half in Africa. Continue reading “Progen Industries.”
Protelos received an EU license in the treatment of postmenopausal osteoporosis, the risk of vertebral the risk of vertebral and hip fractures in the September 2004 to reduce.
Alcohol – branded products is widespread among U.S. Adolescents the the receipt of the products mainly through friends and family, but also distributed through direct purchase said Dr. McClure. This is one of many studies, drinking, and the ownership of these items to teen drinking, and the consistency of results that alcohol brand products is a cause of problematic alcohol use during adolescence. This study shows that the ownership with binge drinking, is a cause of death and injury associated during adolescence. Continue reading “Protelos received an EU license in the treatment of postmenopausal osteoporosis.”
Neurological disorders, identified the gene responsible for one type of Charcot-Marie-Tooth disease, a common inherited neurological disease, thanks to the possibility of appearance of a strain of impaired ‘pale tremor’mice – Gene Discovery Aids Understanding the common Inherited Neurological Disorder in a University of Michigan research lab. The discovery of the gene mutation is a genetic test can be available for people with a less common subtype of the disease – – in, that was not identified until now and had an unknown genetic basis, says Miriam Meisler, senior author of the study. This work appears online ahead of print in the journal Nature.
It is actually a group of disorders that affect the body’s peripheral nerves, with symptoms such as pain and.muscle cause weakness in the feet and legs, foot deformities, mutation. Difficulty walking.
these new capabilities to enhance and supplement existing BGI state-of – the-art bioinformatics software applications for and and population-based research in animals, plants, microbes and human disease areas. Meet the requirements of leading research centers in the analysis and exploration of a variety of biological data. Yingrui Li, Director of Science and Technology Department BGI BGI made of a single first time, BGI is provided detailed insights shed abroad in our latest bioinformatics applications, pipelines and tools. He added.
###Apart Meisler and Chow, UM participants in the study include: Yanling Zhang, Natsuko Jin and Lois Weisman of the Life Sciences Institute, James Dowling of the Department of Neurology and Maja Adamska the Department of Human Genetics The the the National Institutes of Health.. Continue reading “Neurological disorders.”